Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aldo-keto reductase family 1 member C7, pseudogene (AKR1C7P) is a non-protein-coding pseudogene located on human chromosome 10[2][5]. It is related by sequence homology to the AKR1C family of enzymes that typically catalyze steroid hormone modifications[1][3], but AKR1C7P itself is not transcribed into a functional protein. Thus, it is not considered a therapeutic drug target, enzyme, receptor, or transporter. There is no established biological function, disease role, or drug interaction associated with AKR1C7P. AKR1C7P is a pseudogene, not a functional therapeutic target, and should not be used in contexts requiring an active enzyme, receptor, or molecular target designation[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aldo-keto reductase family 1 member C7, pseudogene (AKR1C7P).